Received Feb 20, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | UNK | K011317 | — |
No additional AE reported.; a dose of MMR-II expired on 8/13/2016 and was administered on 11/3/2016.; This spontaneous report was received from a medical assistant referring to a patient of unknown age and gender. The patient's medical history, historical drugs, past drug reactions or allergies, concurrent conditions, and concomitant drugs were not reported. On 03-NOV-2016, the patient was vaccinated with Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) injection (lot#: K011317, expiration date: 13-AUG-2016; dose, strength, and route of administration were not reported) for prophylaxis (expired product administered). No additional adverse event was reported (no adverse event).